190 related articles for article (PubMed ID: 17333333)
1. BARD1 and breast cancer in Poland.
Jakubowska A; Cybulski C; Szymańska A; Huzarski T; Byrski T; Gronwald J; Debniak T; Górski B; Kowalska E; Narod SA; Lubiński J
Breast Cancer Res Treat; 2008 Jan; 107(1):119-22. PubMed ID: 17333333
[TBL] [Abstract][Full Text] [Related]
2. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
3. Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.
Karppinen SM; Barkardottir RB; Backenhorn K; Sydenham T; Syrjäkoski K; Schleutker J; Ikonen T; Pylkäs K; Rapakko K; Erkko H; Johannesdottir G; Gerdes AM; Thomassen M; Agnarsson BA; Grip M; Kallioniemi A; Kere J; Aaltonen LA; Arason A; Møller P; Kruse TA; Borg A; Winqvist R
J Med Genet; 2006 Nov; 43(11):856-62. PubMed ID: 16825437
[TBL] [Abstract][Full Text] [Related]
4. BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
Vahteristo P; Syrjäkoski K; Heikkinen T; Eerola H; Aittomäki K; von Smitten K; Holli K; Blomqvist C; Kallioniemi OP; Nevanlinna H
Eur J Hum Genet; 2006 Feb; 14(2):167-72. PubMed ID: 16333312
[TBL] [Abstract][Full Text] [Related]
5. The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.
Johnatty SE; Beesley J; Chen X; Hopper JL; Southey MC; Giles GG; Goldgar DE; Chenevix-Trench G; Spurdle AB; ;
Breast Cancer Res Treat; 2009 May; 115(1):145-50. PubMed ID: 18481171
[TBL] [Abstract][Full Text] [Related]
6. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
Cybulski C; Lubiński J; Wokołorczyk D; Kuźniak W; Kashyap A; Sopik V; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Górski B; Dębniak T; Narod SA; Akbari MR
Clin Genet; 2015 Oct; 88(4):366-70. PubMed ID: 25330149
[TBL] [Abstract][Full Text] [Related]
7. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.
Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Carrera I; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Santos JL; Jara L
Mol Biol Rep; 2012 Aug; 39(8):8091-8. PubMed ID: 22544576
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Spurdle AB; Marquart L; McGuffog L; Healey S; Sinilnikova O; Wan F; Chen X; Beesley J; Singer CF; Dressler AC; Gschwantler-Kaulich D; Blum JL; Tung N; Weitzel J; Lynch H; Garber J; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Conroy D; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Selkirk CG; Daly M; Isaacs C; Stoppa-Lyonnet D; Sinilnikova OM; Buecher B; Belotti M; Mazoyer S; Barjhoux L; Verny-Pierre C; Lasset C; Dreyfus H; Pujol P; Collonge-Rame MA; ; Rookus MA; Verhoef S; Kriege M; Hoogerbrugge N; Ausems MG; van Os TA; Wijnen J; Devilee P; Meijers-Heijboer HE; Blok MJ; Heikkinen T; Nevanlinna H; Jakubowska A; Lubinski J; Huzarski T; Byrski T; Durocher F; Couch FJ; Lindor NM; Wang X; Thomassen M; Domchek S; Nathanson K; Caligo M; Jernström H; Liljegren A; Ehrencrona H; Karlsson P; ; Ganz PA; Olopade OI; Tomlinson G; Neuhausen S; Antoniou AC; Chenevix-Trench G; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1032-8. PubMed ID: 21393566
[TBL] [Abstract][Full Text] [Related]
9. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
[TBL] [Abstract][Full Text] [Related]
10. The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
Ghadirian P; Robidoux A; Zhang P; Royer R; Akbari M; Zhang S; Fafard E; Costa M; Martin G; Potvin C; Patocskai E; Larouche N; Younan R; Nassif E; Giroux S; Narod SA; Rousseau F; Foulkes WD
Clin Genet; 2009 Nov; 76(5):421-6. PubMed ID: 19863560
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer predisposing alleles in Poland.
Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J
Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls.
Ding DP; Zhang Y; Ma WL; He XF; Wang W; Yu HL; Guo YB; Zheng WL
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1463-8. PubMed ID: 21809034
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.
Sauer MK; Andrulis IL
J Med Genet; 2005 Aug; 42(8):633-8. PubMed ID: 16061562
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of BARD1 in familial breast cancer patients in Japan.
Ishitobi M; Miyoshi Y; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
Cancer Lett; 2003 Oct; 200(1):1-7. PubMed ID: 14550946
[TBL] [Abstract][Full Text] [Related]
16. Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Ratajska M; Antoszewska E; Piskorz A; Brozek I; Borg Å; Kusmierek H; Biernat W; Limon J
Breast Cancer Res Treat; 2012 Jan; 131(1):89-97. PubMed ID: 21344236
[TBL] [Abstract][Full Text] [Related]
17. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
Fabbro M; Schuechner S; Au WW; Henderson BR
Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
[TBL] [Abstract][Full Text] [Related]
18. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
[TBL] [Abstract][Full Text] [Related]
20. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
